Is LY3305677 the same as mazdutide?
Yes. LY3305677 and IBI362 are lab codes listed as other names on this site's mazdutide profile. They name the same drug, which switches on the GLP-1 and glucagon receptors, with a molecular weight of about 4,800 daltons. It was approved in China in 2025 for obesity and type 2 diabetes and is not FDA approved. GLORY-1 included 610 Chinese adults. The codes are lab labels, not a second drug and not a US approval. Full record at /compounds/mazdutide.
Studies in people from the compound pages this answer belongs to
- Mazdutide
- Once-weekly mazdutide in Chinese adults with obesity or overweight (GLORY-1) 2025 PMID 40421736
- Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes 2026 PMID 41407860
- Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity: The GLORY-2 Randomized Clinical Trial 2026 PMID 42251595
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.